Entamoeba histolytica: from adherence to enteropathy

Area of Science:

• Medical Parasitology
• Immunology
• Biochemistry

Background:

• Entamoeba histolytica causes significant global morbidity and mortality from invasive colitis and liver abscesses.
• Understanding parasite adherence, cytolysis, and host immune responses is crucial for developing effective vaccines against amebiasis.

Purpose of the Study:

• To elucidate the biochemical mechanisms underlying Entamoeba histolytica adherence and cytolytic activities.
• To identify key parasite antigens and host immune responses relevant for vaccine development against invasive amebiasis.

Main Methods:

• Investigated the role of the galactose/N-acetyl-D-galactosamine (Gal/GalNAc) inhibitable adherence lectin in parasite attachment.
• Examined the requirements for amebic cytolysis, including lectin adherence, phospholipase A activity, and intracellular pH.
• Assessed the impact of phorbol esters on cytolytic activity and intracellular calcium levels in target cells.
• Characterized the immune recognition of the Gal/GalNAc adherence lectin by human sera and investigated cell-mediated immunity in cured patients.

Main Results:

• The Gal/GalNAc adherence lectin mediates Entamoeba histolytica trophozoite attachment to host cells.
• Amebic cytolysis involves Gal/GalNAc-lectin adherence, phospholipase A activity, and acidic intracellular vesicles.
• Cytolysis is enhanced by protein kinase C activators and involves increased target cell free calcium.
• The Gal/GalNAc adherence lectin is a conserved antigen recognized by human immune sera.
• Patients cured of amebiasis exhibit antigen-specific cell-mediated immunity against Entamoeba histolytica.

Conclusions:

• The Gal/GalNAc adherence lectin is a critical virulence factor and a promising vaccine candidate for eliciting protective IgA antibody responses.
• Additional Entamoeba histolytica antigens capable of inducing cell-mediated amebicidal immunity are also important for vaccine strategies.
• Targeting parasite adherence and cytolytic mechanisms offers a viable approach for developing vaccines against invasive amebiasis.